Clinical Trial Update: D-Serine Monotherapy for Schizophrenia [Phase 1, Phase 2]

View source ↗

Summary

D-Serine monotherapy is being studied for schizophrenia in Phase 1 and Phase 2 trials; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• D-serine (D-serine)

Snippet

Sponsor: Herzog Hospital | Conditions: Schizophrenia | Phase 1, Phase 2 | Status: UNKNOWN